Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies.
Drayton A HammondMegan A RechMitchell J DaleyJohn W DevlinEmily K HodgeKirstin J KoodaIshaq LatHeather A PersonettRussel RobertsGretchen L SachaJoanna L StollingsJoseph M SwansonSeth R BauerPublished in: Journal of the American College of Clinical Pharmacy : JACCP (2019)
Since vasopressin was generically rebranded, most institutions have implemented at least one initiative to reduce vasopressin use and/or educate clinicians about its appropriate use. When vasopressin acquisition costs were considered, pharmacists recommended its use less frequently, particularly in clinical scenarios where its use is controversial.